1. Home
  2. MAX vs ARCT Comparison

MAX vs ARCT Comparison

Compare MAX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAX
  • ARCT
  • Stock Information
  • Founded
  • MAX 2014
  • ARCT 2013
  • Country
  • MAX United States
  • ARCT United States
  • Employees
  • MAX N/A
  • ARCT N/A
  • Industry
  • MAX Industrial Machinery/Components
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAX Industrials
  • ARCT Health Care
  • Exchange
  • MAX Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • MAX 551.1M
  • ARCT 320.8M
  • IPO Year
  • MAX 2020
  • ARCT N/A
  • Fundamental
  • Price
  • MAX $13.26
  • ARCT $18.91
  • Analyst Decision
  • MAX Strong Buy
  • ARCT Strong Buy
  • Analyst Count
  • MAX 6
  • ARCT 10
  • Target Price
  • MAX $18.25
  • ARCT $50.88
  • AVG Volume (30 Days)
  • MAX 650.3K
  • ARCT 493.8K
  • Earning Date
  • MAX 10-29-2025
  • ARCT 11-06-2025
  • Dividend Yield
  • MAX N/A
  • ARCT N/A
  • EPS Growth
  • MAX N/A
  • ARCT N/A
  • EPS
  • MAX N/A
  • ARCT N/A
  • Revenue
  • MAX $1,075,712,000.00
  • ARCT $122,122,000.00
  • Revenue This Year
  • MAX $28.71
  • ARCT N/A
  • Revenue Next Year
  • MAX $9.61
  • ARCT $28.92
  • P/E Ratio
  • MAX N/A
  • ARCT N/A
  • Revenue Growth
  • MAX 116.58
  • ARCT N/A
  • 52 Week Low
  • MAX $7.33
  • ARCT $8.04
  • 52 Week High
  • MAX $20.91
  • ARCT $25.88
  • Technical
  • Relative Strength Index (RSI)
  • MAX 71.30
  • ARCT 64.20
  • Support Level
  • MAX $12.56
  • ARCT $17.70
  • Resistance Level
  • MAX $13.48
  • ARCT $19.50
  • Average True Range (ATR)
  • MAX 0.56
  • ARCT 1.05
  • MACD
  • MAX 0.13
  • ARCT -0.03
  • Stochastic Oscillator
  • MAX 95.10
  • ARCT 82.61

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: